I often see patients with rosacea, a chronic skin condition that causes redness, swelling and sometimes bumps on the face. While there are many factors that may contribute to it, one possible cause is ...

Don’t panic, but tiny mites are likely living on your body. Although this might be disturbing news, don’t stress. It’s quite common for all people to have some Demodex mites since they naturally occur ...

The standard of care for Demodex blepharitis has improved substantially. The current approach involves both identifying and treating the condition effectively. Patients with Demodex blepharitis may ...

The Demodex mite is a ubiquitous microscopic ectoparasite that colonises the pilosebaceous units on human skin, notably the eyelids, where it may contribute to conditions such as blepharitis and ...

Please provide your email address to receive an email when new articles are posted on . A variety of skin diseases can be caused by an imbalance in the immune mechanism, triggered by a high Demodex ...

Welcome to the Mite Party. In its latest effort to raise awareness about demodex blepharitis, an eye condition that affects 25 million Americans, Tarsus Pharmaceuticals is throwing a party — a Mite ...

XDEMVY is the first and only approved therapeutic for Demodex blepharitis, a highly prevalent eyelid disease that impacts approximately 25 million eye care patients in the U.S. XDEMVY targets the root ...

Credit: Tarsus Pharmaceuticals. Xdemvy is supplied as an ophthalmic solution containing lotilaner 0.25% (2.5mg/mL) in a 10mL bottle; it is expected to be available by the end of August 2023. The Food ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Tarsus Pharmaceuticals has announced positive topline ...

IRVINE, Calif., July 25, 2023 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize ...